{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:18:35Z","timestamp":1790497115928,"version":"4.1.0"},"reference-count":58,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijn.ijn_251_17","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T05:15:38Z","timestamp":1531458938000},"page":"257","source":"Crossref","is-referenced-by-count":6,"title":["Fluoroquinolones and BK virus nephropathy: A myth or a reality"],"prefix":"10.25259","volume":"28","author":[{"given":"M. A. M","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A. U","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. F. T","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.236565-1","first-page":"611","volume-title":"Polyomavirus BK","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-2","first-page":"488","volume-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.236565-3","first-page":"582","volume-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"key-10.4103\/0971-4065.236565-4","first-page":"1117","volume-title":"Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year","author":"Wojciechowski","year":"2012","journal-title":"Transplantation"},{"key":"key-10.4103\/0971-4065.236565-5","first-page":"1","volume-title":"Prospective monitoring of BK virus replication in renal transplant recipients","author":"Koukoulaki","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-6","first-page":"S68","volume-title":"BK virus nephritis after renal transplantation","author":"Dall","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.236565-7","first-page":"76","volume-title":"Polyomavirus-associated nephropathy: Update of clinical management in kidney transplant patients","author":"Trofe","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-8","first-page":"S42","volume-title":"Polyomavirus in renal transplantation: A hot problem","author":"Bonvoisin","year":"2008","journal-title":"Transplantation"},{"key":"key-10.4103\/0971-4065.236565-9","first-page":"621","volume-title":"The decade of polyomavirus BK-associated nephropathy: State of affairs","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"key":"key-10.4103\/0971-4065.236565-10","first-page":"131","volume-title":"Polyomavirus nephropathy: A current perspective and clinical considerations","author":"Wiseman","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.236565-11","first-page":"850","volume-title":"Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy","author":"Saad","year":"2008","journal-title":"Transplantation"},{"key":"key-10.4103\/0971-4065.236565-12","first-page":"228","volume-title":"Pharmacotherapeutic options for the management of human polyomaviruses","author":"Roskopf","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"key-10.4103\/0971-4065.236565-13","first-page":"105","volume-title":"Antivirals for the treatment of polyomavirus BK replication","author":"Rinaldo","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.4103\/0971-4065.236565-14","first-page":"751","volume-title":"Nephrotoxicity of intravenous immunoglobulin","author":"Levy","year":"2000","journal-title":"QJM"},{"key":"key-10.4103\/0971-4065.236565-15","first-page":"1034","volume-title":"The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients","author":"Wu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.236565-16","first-page":"1001","volume-title":"Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: Two case reports and review of the literature","author":"Lamoth","year":"2008","journal-title":"Antivir Ther"},{"key":"key-10.4103\/0971-4065.236565-17","first-page":"29","volume-title":"DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities","author":"Levine","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0971-4065.236565-18","first-page":"369","volume-title":"DNA topoisomerases: Structure, function, and mechanism","author":"Champoux","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"key-10.4103\/0971-4065.236565-19","first-page":"427","volume-title":"Origin and evolution of DNA topoisomerases","author":"Forterre","year":"2007","journal-title":"Biochimie"},{"key":"key-10.4103\/0971-4065.236565-20","first-page":"679","volume-title":"Phylogenomics of DNA topoisomerases: Their origin and putative roles in the emergence of modern organisms","author":"Forterre","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key-10.4103\/0971-4065.236565-21","first-page":"421","volume-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","author":"Pommier","year":"2010","journal-title":"Chem Biol"},{"key":"key-10.4103\/0971-4065.236565-22","unstructured":"Hooper D. Quinolones. In: Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 404-23."},{"key":"key-10.4103\/0971-4065.236565-23","unstructured":"Hooper DC, Wolfson JS. Mechanisms of quinolone action and bacterial killing. In: Quinolone Antimicrobial Agents. 2nd ed. Washington, D.C.: American Society for Microbiology; 1993. p. 53-7."},{"key":"key-10.4103\/0971-4065.236565-24","first-page":"1679","volume-title":"Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy","author":"Wu","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0971-4065.236565-25","first-page":"205","volume-title":"Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase","author":"Portolani","year":"1988","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0971-4065.236565-26","first-page":"1885","volume-title":"Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid","author":"Ferrazzi","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0971-4065.236565-27","first-page":"1","volume-title":"Inhibition of simian virus 40 large T antigen helicase activity by fluoroquinolones","author":"Ali","year":"2007","journal-title":"Antivir Ther"},{"key":"key-10.4103\/0971-4065.236565-28","first-page":"1030","volume-title":"The fluoroquinolones","author":"Walker","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0971-4065.236565-29","first-page":"352","volume-title":"Fluoroquinolone toxicity profiles: A review focusing on newer agents","author":"Lipsky","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-30","first-page":"37","volume-title":"Toxicity of quinolones","author":"Stahlmann","year":"1999","journal-title":"Drugs"},{"key":"key-10.4103\/0971-4065.236565-31","first-page":"622","volume-title":"Fluoroquinolone-induced tendinopathy: What do we know?","author":"Harrell","year":"1999","journal-title":"South Med J"},{"key":"key-10.4103\/0971-4065.236565-32","first-page":"2106","volume-title":"Levofloxacin for BK virus prophylaxis following kidney transplantation: A randomized clinical trial","author":"Knoll","year":"2014","journal-title":"JAMA"},{"key":"key-10.4103\/0971-4065.236565-33","first-page":"2193","volume-title":"Sparfloxacin resistance in clinical isolates of streptococcus pneumoniae: Involvement of multiple mutations in gyrA and parC genes","author":"Taba","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-34","first-page":"2792","volume-title":"Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci","author":"Gonz\u00e1lez","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-35","first-page":"2810","volume-title":"DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae","author":"Pan","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-36","first-page":"2956","volume-title":"Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract","author":"Piddock","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-37","first-page":"462","volume-title":"Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season","author":"Jones","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-38","first-page":"116","volume-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"key-10.4103\/0971-4065.236565-39","first-page":"1366","volume-title":"Anti-BK virus activity of ciprofloxacin and related antibiotics","author":"Randhawa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-40","first-page":"115","volume-title":"Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells","author":"Sharma","year":"2011","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0971-4065.236565-41","first-page":"46","volume-title":"Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system","author":"Jeffers-Francis","year":"2015","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0971-4065.236565-42","first-page":"528","volume-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","author":"Leung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-43","first-page":"1176","volume-title":"Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients.Biol Blood Marrow Transplant","author":"Miller","year":"2011","journal-title":""},{"key":"key-10.4103\/0971-4065.236565-44","first-page":"1775","volume-title":"Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases","author":"Toptas","year":"2014","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0971-4065.236565-45","first-page":"274","volume-title":"Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences","author":"Umbro","year":"2013","journal-title":"Virol J"},{"key":"key-10.4103\/0971-4065.236565-46","doi-asserted-by":"crossref","unstructured":"Cekmen MB, Bakirdoven S, Sayan M, Yilmaz A. BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: A case report. Transplant Proc 2012;44:3044-7.","DOI":"10.1016\/j.transproceed.2012.03.059"},{"key":"key-10.4103\/0971-4065.236565-47","first-page":"1298","volume-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","author":"Gabardi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.236565-48","first-page":"107459","volume-title":"Adjuvant ciprofloxacin for persistent BK polyomavirus infection in kidney transplant recipients","author":"Arroyo","year":"2014","journal-title":"J Transplant"},{"key":"key-10.4103\/0971-4065.236565-49","first-page":"1362","volume-title":"BK-virus prophylaxis: Still no answer","author":"Phipps","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key-10.4103\/0971-4065.236565-50","first-page":"433","volume-title":"Early experience with 3-month ciprofloxacin prophylaxis for BK infection in renal transplantation","author":"Patel","year":"2013","journal-title":"Am J Transplant"},{"key":"key-10.4103\/0971-4065.236565-51","first-page":"449","volume-title":"Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication","author":"Koukoulaki","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"key-10.4103\/0971-4065.236565-52","first-page":"583","volume-title":"Efficacy of levofloxacin in the treatment of BK viremia: A multicenter, double-blinded, randomized, placebo-controlled trial","author":"Lee","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.236565-53","first-page":"503","volume-title":"Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae","author":"Garrison","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236565-54","first-page":"2600","volume-title":"Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers","author":"Lubasch","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236565-55","first-page":"61","volume-title":"A 3-month course of ciprofloxacin does not prevent BK virus replication in heavily immunosuppressed kidney-transplant patients","author":"Lebreton","year":"2016","journal-title":"J Clin Virol"},{"key":"key-10.4103\/0971-4065.236565-56","first-page":"152","volume-title":"Fluoroquinolone prophylaxis in preventing BK polyomavirus infection after renal transplant: A systematic review and meta-analysis","author":"Song","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"key":"key-10.4103\/0971-4065.236565-57","unstructured":"ClinicalTrials.gov. Ciprofloxacin for Prevention of BK Infection 17. Available from: https:\/\/www.clinicaltrials.gov\/show\/NCT01789203. [Last accessed on 27 Feb 20]."},{"key":"key-10.4103\/0971-4065.236565-58","first-page":"407","volume-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","author":"Hardinger","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:46:07Z","timestamp":1712173567000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/fluoroquinolones-and-bk-virus-nephropathy-a-myth-or-a-reality\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["236565"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_251_17","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}